6 hours Ago By ABMN Staff
Danaher Co. ( NYSE:DHR – Free Report ) – Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for Danaher in a research report issued on Tuesday, April 22nd. Leerink Partnrs analyst P.
Souda now expects that the conglomerate will post earnings per share of $1.64 for the quarter, down from their prior estimate of $1.74.
The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Leerink Partnrs also issued estimates for Danaher’s Q3 2025 earnings at $1.
75 EPS, Q4 2025 earnings at $2.40 EPS, FY2025 earnings at $7.67 EPS, Q1 2026 earnings at $2.
08 EPS, Q3 2026 earnings at $1.92 EPS, Q4 2026 earnings at $2.63 EPS and FY2026 earnings at $8.
59 EPS. Danaher ( NYSE:DHR – Get Free Report ) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.
88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26.
The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion.
Danaher had a net margin of 16.33% and a return on equity of 10.82%.
Check Out Our Latest Report on DHR Danaher Stock Performance DHR opened at $197.37 on Thursday. Danaher has a 1-year low of $171.
00 and a 1-year high of $281.70. The company has a market capitalization of $141.
06 billion, a price-to-earnings ratio of 37.38, a price-to-earnings-growth ratio of 2.66 and a beta of 0.
86. The business has a 50 day moving average price of $200.87 and a two-hundred day moving average price of $224.
58. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.
40 and a quick ratio of 1.05. Danaher Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Friday, April 25th.
Investors of record on Friday, March 28th were given a dividend of $0.32 per share. This is a boost from Danaher’s previous quarterly dividend of $0.
27. The ex-dividend date of this dividend was Friday, March 28th. This represents a $1.
28 dividend on an annualized basis and a yield of 0.65%. Danaher’s dividend payout ratio (DPR) is presently 24.
85%. Insider Buying and Selling at Danaher In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th.
The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00.
Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.
98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link . Corporate insiders own 11.
10% of the company’s stock. Institutional Trading of Danaher Several large investors have recently added to or reduced their stakes in the business. Heck Capital Advisors LLC bought a new position in shares of Danaher in the 4th quarter valued at approximately $27,000.
GHP Investment Advisors Inc. lifted its position in Danaher by 396.0% during the 1st quarter.
GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Decker Retirement Planning Inc.
bought a new stake in Danaher during the fourth quarter valued at about $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter valued at about $31,000. Finally, Hurley Capital LLC bought a new position in shares of Danaher in the fourth quarter worth about $34,000.
79.05% of the stock is owned by institutional investors. Danaher Company Profile ( Get Free Report ) Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. Read More Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter .
.
